Hutch News

Hutch News

Stories tagged 'Gary Lyman'

Biologics and biosimilars step onto the cancer therapy stage

Q&A: Oncologist and health economist Dr. Gary Lyman discusses a class of treatments on the rise. Will prices follow?

May 31, 2018 | By Diane Mapes / Fred Hutch News Service

Costly biologics and their "generic-ish" counterparts, biosimilars, are about to step into the pharmaceutical spotlight in a big way. We sat down with Fred Hutch's Dr. Gary Lyman, an oncologist and national thought leader on health economics, to learn more about burgeoning biopharmaceuticals.

View story >


Fred Hutch and Microsoft partner for better cancer care delivery

Project to flag treatment-related symptoms early is revealed at Seattle conference

May 4, 2018 | By Sabin Russell / Fred Hutch News Service

A Fred Hutch-Microsoft partnership to develop and pilot test technology to help cancer patients was revealed at the fifth annual Value in Cancer Care Summit, held Thursday in Seattle.

View story >


Hutch health economics group releases its first public report

Community Cancer Care Report on quality and cost is the product of five years of stakeholder collaboration

May 1, 2018 | By Diane Mapes / Fred Hutch News Service

Fred Hutch’s HICOR releases its Community Cancer Care Report, the first public report linking quality and cost measures for cancer clinics.

View story >



(RSS feeds are best viewed in browsers other than Chrome)

Editor's Picks

GIVE NOW &
SAVE LIVES

Support our quest for cures

Story Archive


Publications

Magazine Archive
Back issues of Hutch Magazine

Financial Reporting
Fiscal highlights & Annual Reports

Science Spotlight
Monthly review of Center-authored papers



Fred Hutch News

        Get updates via email.